Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DULOXETINE Cause International normalised ratio increased? 51 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 51 reports of International normalised ratio increased have been filed in association with DULOXETINE (Duloxetine Hydrochloride). This represents 0.1% of all adverse event reports for DULOXETINE.

51
Reports of International normalised ratio increased with DULOXETINE
0.1%
of all DULOXETINE reports
1
Deaths
22
Hospitalizations

How Dangerous Is International normalised ratio increased From DULOXETINE?

Of the 51 reports, 1 (2.0%) resulted in death, 22 (43.1%) required hospitalization.

Is International normalised ratio increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DULOXETINE. However, 51 reports have been filed with the FAERS database.

What Other Side Effects Does DULOXETINE Cause?

Nausea (7,355) Dizziness (6,983) Drug withdrawal syndrome (6,503) Headache (5,541) Fatigue (5,309) Insomnia (5,270) Anxiety (4,973) Paraesthesia (4,854) Drug ineffective (4,829) Hyperhidrosis (4,101)

What Other Drugs Cause International normalised ratio increased?

WARFARIN (5,622) RIVAROXABAN (863) ACETAMINOPHEN (533) ASPIRIN (448) APIXABAN (317) CLOPIDOGREL BISULFATE (314) FLUINDIONE (286) AMIODARONE (277) FUROSEMIDE (277) DABIGATRAN ETEXILATE (223)

Which DULOXETINE Alternatives Have Lower International normalised ratio increased Risk?

DULOXETINE vs DUPILUMAB DULOXETINE vs DURAGESIC DULOXETINE vs DUROGESIC DULOXETINE vs DUROTEP MT DULOXETINE vs DURVALUMAB

Related Pages

DULOXETINE Full Profile All International normalised ratio increased Reports All Drugs Causing International normalised ratio increased DULOXETINE Demographics